Bridgewater, NJ, United States of America

Nevakar Inc.


USPTO Granted Patents = 22

% Expired Patents = 4.5

Trademarks = 2

Forward Citations = 95

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Kumaresh Soppimath (22 out of 62 patents)

silverMedal Prem Sagar Akasapu (19 out of 28 patents)

bronzeMedal Iouri V Ilitchev (13 out of 22 patents)

4.  Navneet Puri (10 out of 14 patents)

5.  Tushar Hingorani (9 out of 32 patents)

6.  Irfan A Mohammed (7 out of 15 patents)

7.  Vivek Yadav (4 out of 4 patents)

8.  Milan Indu Patel (3 out of 101 patents)

9.  Reema Ajitkumar Puri (3 out of 9 patents)

10.  Pooja H Tendulkar (3 out of 8 patents)

11.  Tao Zhang (3 out of 3 patents)

12.  Jack Martin Lipman (2 out of 5 patents)

13.  Varun Khurana (2 out of 4 patents)

14.  Sriramya Garapati (2 out of 2 patents)


22 patents:

Company Overview
Nevakar Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, focused on developing innovative therapies to address unmet medical needs. The organization specializes in the formulation and delivery of complex injectable products, leveraging advanced drug delivery technologies. With a commitment to enhancing patient outcomes, Nevakar is engaged in research across various therapeutic areas, including ophthalmology and oncology, aiming to improve treatment options and accessibility for patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Nevakar Inc. USPTO Patent Assignee Logo
22 Patents

#16 in Bridgewater, NJ

#579 in New Jersey

#15,051 in US

#28,807 in the World

Bridgewater, NJ (US)
Bridgewater, NJ, United States of America
Forward Citations = 95

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nevakar Inc.. Retrieved from https://idiyas.com/company/nevakar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…